Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19
Clinical trial NCT05620160 · COMPLETED
Trial details
- NCT number
- NCT05620160
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-12
- Primary completion
- 2023-01-19
- Enrollment
- 1359
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.